BBIO icon

BridgeBio Pharma
BBIO

Overview Fund Activity

213 hedge funds and large institutions have $2.53B invested in BridgeBio Pharma in 2023 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 76 increasing their positions, 58 reducing their positions, and 24 closing their positions.

Holders
213
Holders Change
+34
Holders Change %
+18.99%
% of All Funds
3.41%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.13%
New
59
Increased
76
Reduced
58
Closed
24
Calls
$53.7M
Puts
$52M
Net Calls
+$1.75M
Net Calls Change
+$435K

Top Buyers

1
CAM
1
Cormorant Asset Management
Massachusetts
$75.6M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$200M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$34.9M
4
LCM
4
Laurion Capital Management
New York
$58.2M
5
FLSM
5
Frazier Life Sciences Management
California
$19.4M

Top Sellers

1
State Street
1
State Street
Massachusetts
$85.3M
2
Citadel Advisors
2
Citadel Advisors
Florida
$4.75M
3
HA
3
HHLR Advisors
Cayman Islands
$66M
4
AIG
4
American International Group
New York
$44.8M
5
BlackRock
5
BlackRock
New York
$151M
Name Market Value Shares Shares
Change 		Shares
Change %
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$515M 31,060,971 – –
Viking Global Investors
2
Viking Global Investors
Connecticut
$441M 26,620,991 – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$200M 12,063,256 +1,471,801 +14%
BlackRock
4
BlackRock
New York
$151M 9,117,781 -650,410 -7%
ACM
5
Aisling Capital Management
New York
$101M 6,068,125 – –
State Street
6
State Street
Massachusetts
$85.3M 5,143,013 -3,701,930 -42%
CAM
7
Cormorant Asset Management
Massachusetts
$75.6M 4,557,414 +3,188,235 +233%
HA
8
HHLR Advisors
Cayman Islands
$66M 3,978,410 -1,208,815 -23%
LCM
9
Laurion Capital Management
New York
$58.2M 3,512,759 +1,289,505 +58%
AIG
10
American International Group
New York
$44.8M 2,704,374 -1,015,711 -27%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$37.4M 2,253,158 +187,251 +9%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$37M 2,232,021 -468,803 -17%
Fidelity Investments
13
Fidelity Investments
Massachusetts
$34.9M 2,104,234 +1,401,129 +199%
PA
14
Perceptive Advisors
New York
$31.6M 1,907,033 +210,000 +12%
SUT
15
SC US (TTGP)
California
$30.8M 1,860,364 – –
Citigroup
16
Citigroup
New York
$25.7M 1,547,045 +162,116 +12%
PAMS
17
Pictet Asset Management (Switzerland)
Switzerland
$23.9M 1,442,432 +901,628 +167%
Bank of America
18
Bank of America
North Carolina
$22.6M 1,365,057 +519,245 +61%
OCA
19
Octagon Capital Advisors
New York
$22.2M 1,338,160 +404,417 +43%
FLSM
20
Frazier Life Sciences Management
California
$19.4M 1,171,650 +1,171,650 New
Marshall Wace
21
Marshall Wace
United Kingdom
$18M 1,084,595 +1,084,595 New
Ensign Peak Advisors
22
Ensign Peak Advisors
Utah
$17.9M 1,080,259 +256,300 +31%
Voloridge Investment Management
23
Voloridge Investment Management
Florida
$17.3M 1,042,486 +411,775 +65%
APM
24
Avidity Partners Management
Texas
$16.6M 1,000,000 +1,000,000 New
Goldman Sachs
25
Goldman Sachs
New York
$16.2M 975,231 -380,065 -28%
1
2 3 4 5